SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-090552
Filing Date
2020-08-05
Accepted
2020-08-05 07:05:17
Documents
3
Period of Report
2020-08-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026669-1_8k.htm 8-K 19933
2 EXHIBIT 99.1 tm2026669d1_ex99-1.htm EX-99.1 18059
3 GRAPHIC tm2026669d1_ex99-1img01.jpg GRAPHIC 3407
  Complete submission text file 0001104659-20-090552.txt   43936
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 201075588
SIC: 2834 Pharmaceutical Preparations